Nymox Pharmaceutical Corp

NYMXF

Exchange: OTC
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0001018735

SEC filings (opens in a new tab)

No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.

Superinvestors holding NYMXF, Q2 2026

See all superinvestors

No superinvestor reported holding NYMXF in Q2 2026.